Biocon’s management expects formulations business to drive growth in the second half of the current financial year. Previous Post Reliance Retail signs consumer safety pledge with govt on National Consumer Day Next Post Aarti Drugs shares jump 11% after USFDA's clearance for its Tarapur facility Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
